| Trial Name | Description |
| ARREST-2 MS |
Dr. Timothy Nguyen Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial |
| IND.228 |
Dr. Eric Winquist A Phase II Study of Durvalumab and Tremelimumab in Patients with Advanced Rare Tumours. |
| GARNET MS |
Dr. S. Welch A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors |
| PM.1 MS |
Dr. S. Welch Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) A Phase II Basket Trial |
| STOP-NSCLC |
Dr. David Palma Sterotactic Radiotherapy for Oligo-Progressive Non-Small Cell Lung Cancer |
| SABR-COMET-3 |
Phase III Randomized Controlled Trial and Economic Evaluation of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 metastases) cancer. SABR-COMET-3 |
| RT-NOW MS |
Dr. D. Palma Is radiation-before-pathology a feasible approach in the palliative oncology setting? A pragmatic clinical trial |
| NAVIGATE MS |
Dr. S Ernst A Phase 2 Basket Study of the Oral TRK Inhibitor Larotrectinib in Subjects with NTRK Fusion-Positive Tumors. For melanoma and non-secretory breast cancer. |
| SABR-SYNC MS |
Dr. D. Palma A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients with Up to 10 Oligometastases and a Synchronous Primary Tumor |
| SUPR-3D |
Dr. Joanna Laba SUPR-3D: A Randomized Phase III Trial Comparing Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients with Bone Metastases. |
| SEACRAFT-1 MS |
Dr. E. Winquist Not open yet - An open-label study to assess the safety and efficacy of naporafenib (ERAS-254) administered with trametinib in previously treated patients with locally advanced unresectable or metastatic solid tumor malignancies with RAS Q61X mutations |
| Keynote 587 MS |
A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial |
| TAPISTRY MS |
Dr. S. Welch Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational For You (TAPISTRY) Phase II Platform Trial |
| CATCH-R GYN |
Dr. Stephen Welch "Not Open Yet" CATCH-R: A Rollover Study to Provide Continued Access to Clinical Therapy with Rucaparib |
| FMT-LUMINate NSCLC-MEL |
Dr. J. Raphael Phase II Trial of Fecal Microbial Transplantation in Patients with Advanced Non-Small Cell Lung Cancer and Melanoma Treated with Immune Checkpoint Inhibitors (FMT-LUMINate) |
| INCB99280-204 |
Dr. Daniel Breadner Not Yet Open - A Phase 1 Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation |